Top After-Market NASDAQ Movers (Einstein Noah, Enphase, Cyclacel, Zogenix, M B T Coffee, Pain Therapeutics, Amarin, Comtech, Metabolix)

   on December 06 2012 11:55 PM

The top after-market NASDAQ gainers Thursday were Einstein Noah Restaurant Group Inc, Enphase Energy Inc, Cyclacel Pharmaceuticals Inc, Zogenix Inc and M B T Financial Inc.

The top after-market NASDAQ losers Monday were Pain Therapeutics Inc, Amarin Corporation, Comtech Telecommunications and Metabolix Inc.  

Gainers

Einstein Noah Restaurant Group Inc (BAGL) shares climbed 7.66 percent to $17.00 in post-market trading. The company Thursday announced that its board had completed the strategic alternatives review process by recapitalizing the company and declaring a one-time special dividend to shareholders of $4.00 per share.

Enphase Energy Inc (ENPH) shares gained 6.47 percent to $2.90 in post-market trading. The stock has a 52-week low of $1.92, a 52-week high of $9.57 and $111.06 million in market capitalization.

Cyclacel Pharmaceuticals Inc (CYCC) shares rose 5.82 percent to $6.91 in post-market trading. The company shares lost 13.97 percent on regular trade.  

Zogenix Inc (ZGNX) shares advanced 5.51 percent to $2.49 in post-market trading. The stock has a 52-week low of $1.31, a 52-week high of $3.30 and $237.57 million in market capitalization.

M B T Financial Inc (MBTF) shares went up by 3.00 percent to $2.40 in post-market trading. The stock has a 52-week low of $0.80, a 52-week high of $3.70 and $40.37 million in market capitalization.

Losers

Pain Therapeutics Inc (PTIE) shares declined 22.19 percent to $2.42 in post-market trading. The company shares have a 52-week trading range of $2.69-$5.86 and $140.07 million in market capitalization.

Amarin Corporation (AMRN) shares slumped 18.41 percent to $9.75 in post-market trading. The company announced Thursday a $100 million non-equity financing with an investment fund managed by Pharmakon Advisors.

Comtech Telecommunications Corporation (CMTL) shares dropped 12.67 percent to $22.53 in post-market trading.  The stock has a 52-week trading range of $23.90 - $34.89 and $448.12 million in market capitalization.

Metabolix Inc (MBLX) shares fell 4.63 percent to $2.06 in post-market trading. The stocks surged over 44 percent in regular trade Thursday after the company announced that it secured UCLA engineering ARPA-E-grant for improving the productivity of making bio-fuels in plants.  

Join the Discussion